Skip to main content
Prescription only

Arexvy

Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted

Listed by GlaxoSmithKline Biologicals SA

Form
Kit

What it contains

No active ingredients listed in the FDA record.

FDA record

Dosage form Kit
Approval route BLA — biologic licence
NDC code 58160-882
FDA application BLA125775
Package sizes listed 1
Marketed since April 2026

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.